📚 New @iprolepsis.bsky.social publication by Hojeij et al. in BMJ Open presents the PDPID study protocol, combining clinical, biological, environmental and digital data to support PsA flare detection and prediction.
@iprolepsis.bsky.social
iPROLEPSIS
@iprolepsis.bsky.social
🏥 iPROLEPSIS: Psoriatic arthritis inflammation explained through multi-source data analysis guiding a novel personalised digital care ecosystem⚕️ iPROLEPSIS receives funding from the European Union under Grant Agreement No. 101095697.
@iprolepsis.bsky.social@iprolepsis.bsky.social🔎 What are the drivers of inflammation in psoriatic arthritis?
A new report from @iprolepsis.bsky.social explores drivers of inflammation in PsA using retrospective and prospective data.
@iprolepsis.bsky.socialHow do you build digital tools that work for people with #PsoriaticArthritis?
You co-create them.
New @iprolepsis.bsky.social report shows how 780+ patients and 30 clinicians shaped our patient apps, serious games and clinician dashboard.
Full report: zenodo.org/records/2265...
@iprolepsis.bsky.social@iprolepsis.bsky.social has published an updated report on the state of the art and relevant datasets for psoriatic arthritis, covering symptoms, flare-related factors, monitoring approaches and predictive modelling.
@iprolepsis.bsky.socialNew @iprolepsis.bsky.social publication, now available as Early Access in IEEE Access on @IEEEXplore. The study presents a Dynamic Difficulty Adjustment system to personalise difficulty in serious games for psoriatic arthritis.
ieeexplore.ieee.org/document/116...
@iprolepsis.bsky.socialNew @iprolepsis.bsky.social publication, now available as Early Access on IEEE Xplore.
The study presents two co-designed exergames, The Spy and Zen Forest, and explores their use as sources of digital biomarkers for psoriatic arthritis.